
Lupin Limited has informed the Exchange about press release dated 07-Sep-2022 titled Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines.
Filed with NSE ·

Lupin Limited has informed the Exchange about press release dated 07-Sep-2022 titled Lupin and DKSH Sign an Exclusive Licensing and Supply Agreement to Market Five Biosimilar Candidates in the Philippines.
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin